Aromatase inhibitors: all 608 studies that test it
Page 4 of 7. Open to participants first (88), then studies with results posted, then the rest; newest registration first within each.
- Efficacy of Letrozole in Recurrent Ovarian CancerTerminatedNCT04421547Phase 3
- Abemaciclib and Letrozole to Treat Endometrial CancerActive, not recruitingNCT04393285Phase 2
- Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS)Active, not recruitingNCT04383275Phase 2
- Endometrial Preparation by Short Course of Letrozole Before Hysteroscopic Removal of Endocavitary LesionsStatus unknownNCT04364581Phase 4
- Cost Effectiveness Analysis for Induction of Ovulation in the Polycystic Ovary Syndrome by Letrozole Versus Clomiphene CitrateStatus unknownNCT04361175Early Phase 1
- Impact of Endocrine Therapy and Abemaciclib on Host and Tumor Immune Cell Repertoire/Function in Advanced ER+/HER2- Breast CancerCompletedNCT04352777Phase 2
- Letrozole in Tubal Ectopic PregnancyStatus unknownNCT04341545Phase 3
- BMI Effect on the Response to Ovulation Induction in Letrozole vs ClomidStatus unknownNCT04331197Phase 4
- Hormone Secretion in Transgender MalesWithdrawnNCT04321551Phase 4
- The Aromatase Inhibitor and Gnrh Antagonist Versus Methotrexate for Management of Undisturbed Ectopic PregnancyStatus unknownNCT04308343Not applicable
- Controlled Ovarian Stimulation in Newly Diagnosed Breast Cancer PatiEnts (fAMHOPE)TerminatedNCT04289805Phase 4
- Extended Letrozole Regimen Co-treatment With Gonadotropin Releasing Hormone Antagonist Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in Poor Responders Undergoing IVF-ETStatus unknownNCT04268927Phase 2
- Niraparib Plus Aromatase Inhibitors for Luminal-like(HER2-,ER+) and gBRCA or HDR+ Metastatic Breast Cancer (LUZERN)CompletedNCT04240106Phase 2
- Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7)TerminatedNCT04227327Phase 2
- Effectiveness of Pretreatment Letrozole Versus Misoprostol Alone in Missed AbortionStatus unknownNCT04194658Phase 2
- Different Protocols in Ovarian Stimulation in Intracytoplasmic Sperm Injection CyclesWithdrawnNCT04193930Not applicable
- The Outcomes of ICSI Cycles With and Without LetrozoleStatus unknownNCT04159649Phase 4
- Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast CancerActive, not recruitingNCT04158362Phase 3
- Palbociclib Plus Letrozole in Hormone Receptor Positive Residual Disease After Neoadjuvant ChemotherapyCompletedNCT04130152Early Phase 1
- Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerActive, not recruitingNCT04095364Phase 3
- Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast CancerWithdrawnNCT04088032Early Phase 1
- Follicular Synchronization in PCOS Patients Undergoing ICSICompletedNCT04069117Phase 4
- Abemaciclib and Letrozole in Treating Patients With Endometrial CancerCompletedNCT04049227Early Phase 1
- Capecitabine in Combination With Aromatase Inhibitor Versus Aromatase Inhibitors, in Hormonal Receptor Positive Recurrent or Metastatic Breast Cancer Patients, Randomized Controlled StudyStatus unknownNCT04012918Phase 2
- Letrozole for Frozen Embryo Transfer (FET) in Patients With Polycystic Ovary Syndrome (PCOS)WithdrawnNCT04002635Phase 4
- Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT)CompletedNCT03948568Phase 4
- Palbociclib Plus Letrozole Treatment After Progression to Second Line Chemotherapy for Women With ER/PR-positive Ovarian CancerCompletedNCT03936270Phase 2
- Phase IB & II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR+, HER2+ Advanced Breast Cancer PatientsStatus unknownNCT03913234Phase 1/2
- Does Letrozole Improve Pregnancy Outcome in Fresh Embryo Transfer IVF/ICSI Cycle?Status unknownNCT03901170Phase 4
- Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast CancerCompletedNCT03900884Phase 1
- PersonaLized neoAdjuvant Strategy ER Positive and HER2 Negative Breast Cancer TO Increase BCS RateActive, not recruitingNCT03900637Phase 2
- Letrozole Pretreatment With Misoprostol fInduction of Abortion In First-Trimester Missed MiscarriageStatus unknownNCT03628625Phase 2
- Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast CancerCompletedNCT03628066Phase 2
- Endometrial Preparation in Frozen Embryo Transfer CyclesStatus unknownNCT03540979Not applicable
- Neo-adjuvant Chemotherapy With Letrozole in Patients With Estrogen Receptor Positive/HER-2 Negative Breast CancerStatus unknownNCT03497702Phase 2
- Intrauterine Insemination With Letrozole Versus in Natural CycleCompletedNCT03455426Not applicable
- Aromatase Plus GnRH Analogue Versus GnRH Analog Alone in AdenomyosisActive, not recruitingNCT03421639Phase 4
- Evaluation of IM Letrozole ISM® Pharmacokinetics, Safety, and Tolerability in Healthy Post-menopausal Women (LISA-1)CompletedNCT03401320Phase 1
- Different Methods of Termination of Second Trimester AbortionStatus unknownNCT03400683Not applicable
- IMPACT: A Randomized WOO Study of Novel Therapeutic Agents in Women Triaged to Primary Surgery for EOCCompletedNCT03378297Early Phase 1
- Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast CancerStatus unknownNCT03373708Phase 2/3
- A Randomized, Open-label, Multi-center Phase IV Study Evaluating Palbociclib Plus Endocrine Treatment Versus a Chemotherapy-based Treatment Strategy in Patients With Hormone Receptor Positive / HER2 Negative Breast Cancer in a Real World Setting (GBG 93 - PADMA Study).CompletedNCT03355157Phase 4
- A Single Dose Trial to Evaluate the Pharmacokinetics of Testosterone and AnastrozoleCompletedNCT03314298Phase 1
- Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic BreastActive, not recruitingNCT03304080Phase 1/2
- Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene MutationCompletedNCT03285802Phase 2/3
- Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer.Active, not recruitingNCT03283384Phase 2
- Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer PatientsCompletedNCT03272477Phase 2
- Enobosarm and Anastrozole in Pre-menopausal Women With High Mammographic Breast DensityCompletedNCT03264651Phase 1
- Neadjuvant Multi-agent Chemotherapy or Letrozole Plus Ribociclib in Luminal B/HER2-negative Breast Cancer.CompletedNCT03248427Phase 2
- Induction of Ovulation Using Clomiphene Citrate and N-acetyl Cysteine Versus LetrozoleCompletedNCT03241472Phase 3
- Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast CancerWithdrawnNCT03238703Phase 4
- The EMPOwER Study Evaluating Multiparameter Gene Testing as a Predictor of Short Term Endocrine Therapy Response in Hormone Receptor Positive Breast CancersStatus unknownNCT03211572Phase 2
- Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positive and HER2 Negative Metastatic Breast CancerStatus unknownNCT03204734Phase 2
- Letrozole Step-up Protocol for Ovulation Induction in Infertile Women With PCOSCompletedNCT03181919Not applicable
- A Study to Evaluate Exemestane Tablets Combined With Ovarian Function Suppression/Ablation in Treatment of Premenopausal Breast Cancer Patients With CYP2D6*10 Mutations （STEP）Status unknownNCT03137368Phase 3
- Letrozole in Clomiphene Resistant Infertile Women With Polycystic Ovarian SyndromeStatus unknownNCT03135301Phase 3
- Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast CancerTerminatedNCT03128619Phase 1
- Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism (IHH)TerminatedNCT03118479Phase 1
- HOrmone Therapy Immediately After Histological Diagnosis of Breast CancerStatus unknownNCT03111615Phase 4
- Letrozole Versus Laparoscopic Ovarian Drilling in Polycystic Ovary SyndromeStatus unknownNCT03009838Phase 3
- A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial CarcinomaActive, not recruitingNCT03008408Phase 2
- Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer PatientsCompletedNCT02995772Phase 3
- Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast CancerCompletedNCT02980965Phase 3
- A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast CancerCompletedNCT02958852Phase 2
- Effect of Addition of Aromatase Inhibitor to Ovarian Stimulation Therapy in IVF TreatmentCompletedNCT02946684Phase 2/3
- Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast CancerActive, not recruitingNCT02942355Phase 2
- Mapping the Endocrine Determinants of Ovarian Stimulation to Optimize Outcomes in Fresh Embryo Transfer CyclesCompletedNCT02939898Phase 2/3
- CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast CancerActive, not recruitingNCT02918084Phase 3
- Letrozole in Stimulated IVF CyclesCompletedNCT02912988Phase 3
- Effect of Letrozole on Seminal Parameters in Men With Non Obstructive Azoospermia and Severe Oligozoospermia.CompletedNCT02900105Phase 3
- Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast CancerCompletedNCT02820961Phase 1
- Palbociclib and FES PETCompletedNCT02806050Phase 2
- Phase 0 Study of Metronomic Oral Vinorelbine and Letrozole in HR+/HER2-negative Early Breast Cancer Patients (VENTANA)CompletedNCT02802748Early Phase 1
- Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast CancerStatus unknownNCT02769104Phase 3
- Cardiovascular Outcomes of Low TestosteroneCompletedNCT02758431Not applicable
- A Trial of Neoadjuvant Everolimus Plus Letrozole Versus FEC in Women With ER-positive, HER2-negative Breast CancerCompletedNCT02742051Phase 2
- Role of Aromatase Inhibitor to Enhance Ovulation in Poor Responder During Induction With Short Antagonist Protocol in Cases of ICSICompletedNCT02741154Phase 4
- Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial CancerCompletedNCT02730429Phase 2
- Administration of Single High Dose Letrozole for Ovulation InductionCompletedNCT02703649Phase 4
- Radiological and Biological Tumoural and Peri-tumoural Factors in Neoadjuvant Endocrine-treated Breast CancersCompletedNCT02701348Not applicable
- Preventive Application of Letrozole Decrease Incidence of Early Onset of OHSSCompletedNCT02670304Phase 4
- Fertility Preservation in Breast Cancer PatientsCompletedNCT02661932Phase 4
- A Comparison of Letrozole and Clomifene CitrateStatus unknownNCT02647424Not applicable
- PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC TrialActive, not recruitingNCT02624973Phase 2
- Nintedanib+Letrozole in Postmenopausal Women With Breast Cancer: Clinical Trial Safety and PharmacodynamicsCompletedNCT02619162Phase 1
- Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node MetastasesActive, not recruitingNCT02603679Phase 2
- A Study of Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBCStatus unknownNCT02592746Phase 2
- Addition of Aromatase at the Navelbine in Pretreated Metastatic Breast Cancer.TerminatedNCT02585388Phase 2
- Study in Letrozole Combined With Metronomic Oral Cyclophosphamide in Elderly Metastasis Breast Cancer PatientsCompletedNCT02583828Not applicable
- Neoadjuvant Lenvatinib Combined With Letrozole in Hormone Receptor Positive Breast CancerActive, not recruitingNCT02562118Phase 1/2
- Letrozole Versus Clomiphene Citrate for Ovulation Induction in Women With Poly Cystic Ovary Syndrome ( PCOS )Status unknownNCT02551367Phase 2
- Effect of Concomitant Use of an Antimycotic, an Antibiotic, a Spermicide or Tampons on Pharmacokinetics of Anastrozole and Levonorgestrel Released From Intra-vaginal RingCompletedNCT02545452Phase 1
- Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese SubjectsCompletedNCT02538484Early Phase 1
- Neoadjuvant Aromatase Inhibitor(AI) With Ovarian Suppression Versus Chemotherapy in Premenopausal Breast Cancer PatientsTerminatedNCT02532400Phase 3
- The Effect of 7 Days of Letrozole Pretreatment Combined With Misoprostol on the Placental and Decidual TissuesCompletedNCT02457312Phase 2
- Safety of OFS Combined With AI Endocrine Therapy in Chinese Premenopausal Breast Cancer PatientsCompletedNCT02440230Phase 2
- Letrozole Pretreatment With Misoprostol for Second-Trimester Medical AbortionCompletedNCT02405156Phase 2/3
- Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast CancerStatus unknownNCT02404051Phase 3
- Use of Letrozole Pretreatment With Misoprostol for First-Trimester Medical AbortionCompletedNCT02401425Phase 2/3
- Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal WomenCompletedNCT02400567Phase 2